Infective endocarditis caused by USA300 methicillin-resistant Staphylococcus aureus (MRSA)

International Journal of Antimicrobial Agents

Volumn 30, Issue 1, 2007, Pages 72-77

  Haque, N Z ^a   Davis, S L ^a,b   Manierski, C L ^a   Vager, D ^a   Donabedian, S M ^a   Perri, M B ^a   Sabbagh, R ^a   Cheema, F ^a   Zervos, M J ^a,c  

^a HENRY FORD HEALTH SYSTEM   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CA MRSA; Endocarditis; USA300; Vancomycin

Indexed keywords

CLINDAMYCIN; DAPTOMYCIN; GENTAMICIN; RIFAMPICIN; VANCOMYCIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL ENDOCARDITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEART FAILURE; HEART VALVE REPLACEMENT; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; TREATMENT DURATION;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; CLUSTER ANALYSIS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DNA FINGERPRINTING; ELECTROPHORESIS, GEL, PULSED-FIELD; ENDOCARDITIS, BACTERIAL; FEMALE; HOSPITALIZATION; HOSPITALS, TEACHING; HOSPITALS, URBAN; HUMANS; LENGTH OF STAY; MALE; METHICILLIN RESISTANCE; MIDDLE AGED; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 34249866196     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2007.02.007     Document Type: Article

References (15)

1. Bashore T.M., Cabell C., and Fowler Jr. V. Update on infective endocarditis. Curr Probl Cardiol 31 (2006) 274-352
2. Deresinski S. Methicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odyssey. Clin Infect Dis 40 (2005) 562-573
3. Saravolatz L.D., Markowitz N., Arking L., Pohlod D., and Fisher E. Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak. Ann Intern Med 96 (1982) 11-16
4. Levine D.P., Cushing R.D., Jui J., and Brown W.J. Community-acquired methicillin-resistant Staphylococcus aureus endocarditis in the Detroit Medical Center. Ann Intern Med 97 (1982) 330-338
5. Fridkin S.K., Hageman J.C., Morrison M., et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 352 (2005) 1436-1444
6. McDougal L.K., Steward C.D., Killgore G.E., Chatiram J.M., McAllister S.K., and Tenover F.C. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 41 (2003) 5113-5120
7. Tenover F.C., McDougal L.K., Goering R.V., et al. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol 44 (2006) 108-118
8. Seybold U., Kourbatova E.V., Johnson J.G., et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 42 (2006) 647-656
9. Bahrain M., Vasiliades M., Wolff M., and Younus F. Five cases of bacterial endocarditis after furunculosis and the ongoing saga of community-acquired methicillin-resistant Staphylococcus aureus infections. Scand J Infect Dis 38 (2006) 702-707
10. Durack D.T., Lukes A.S., and Bright D.K. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am J Med 96 (1994) 200-209
11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Fifteenth Informational Supplement. M-100-S15. Wayne, PA: CLSI; 2005.
12. Cosgrove S.E., Sakoulas G., Perencevich E.N., Schwaber M.J., Karchmer A.W., and Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36 (2003) 53-59
13. Baba T.F., Takeuchi F., Kuroda M., et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 359 (2002) 1819-1827
14. Hidron A.I., Kourbatova E.V., Halvosa J.S., et al. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin Infect Dis 41 (2005) 159-166
15. Miller L.G., Perdreau-Remington F., Rieg G., et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 352 (2005) 1445-1453